May 2018 Steering Committee and Onboarding Meeting: Nudge, PRIM-ER, P4TH, EMBED, ACP PEACE, and HiLo

Steering Committee Meeting

May 14-16, 2018
Bethesda, MD

Main Purpose

Day 1: Welcome the new UG3 NIH Collaboratory Trials; provide introductions, an overview of the Collaboratory, and an understanding of the Core Working Groups; and discuss lessons learned, data sharing, and current ethics and regulatory issues.

Day 2: Celebrate the Collaboratory's progress; kick off the next 5 years; receive updates from the Core Working Groups; and hear about the top barriers/challenges and lessons learned from the UH3s.

Day 3: Intensive workshop to start discussions on embedded A vs. B pragmatic clinical trials.

Monday, May 14, 2018

Welcome, Opening Remarks, and Introductions
David Shurtleff, PhD; Richard Hodes, MD; Lesley Curtis, PhD

Overview of a Cooperative Agreement
Wendy Weber, ND, PhD, MPH

Overview of the NIH HCS Research Collaboratory Program
David Shurtleff, PhD

Panel of Directors: Richard Hodes, MD; Wilson Compton, MD; David Murray, PhD; Bill Riley, PhD; Gary Gibbons, MD; Rob Star, MD

Collaboratory Coordinating Center Overview and Goals
Adrian Hernandez, MD, MHS

Rethinking Clinical Trials: A Living Textbook of Pragmatic Clinical Trials
Jonathan McCall, MS

Policies and Guidance Documents

NIH Collaboratory Data Sharing Policy and Considerations
Adrian Hernandez, MD, MHS

Publications and Products Process
Eric Larson, MD, MPH

Data Quality
Rachel Richesson, PhD, MPH

New UG3 NIH Collaboratory Trials Updates
Brief overview of the projects

NIH and Other Requirements for ClinicalTrials.gov Reporting
Deborah Zarin, MD

Results Reporting of ePCTs
Adrian Hernandez, MD, MHS

Distributed Research Network Query Capabilities
Richard Platt, MD; Lesley Curtis, PhD

Closing Remarks
David Shurtleff, PhD; Richard Hodes, MD; Lesley Curtis, PhD 

Tuesday, May 15, 2018

Welcome and Opening Remarks
David Shurtleff, PhD; Richard Hodes, MD; Lesley Curtis, PhD

Landscape of National ePCT Initiatives
Explanation of initiatives that are promoting ePCTs and future directions

Health Systems Engagement Issues and Lessons Learned from the Health Care Systems Interactions Core
Eric Larson, MD, MPH

UH3 NIH Collaboratory Trials
Top barriers/challenges and recent generalizable lessons learned

 

Tuesday, May 15, 2018 (Continued)

Discussion From New UG3 NIH Collaboratory Trials
Overview of project and discussion

CMS Quality Measures
Reena Duseja, MD

Lessons Learned From Core Groups
Discussion on generalizable knowledge created out of the Cores, how it can be used, and future work of the Cores

Data Sharing Principles and Lessons Learned
Greg Simon, MD, MPH

Closing Remarks
David Shurtleff, PhD; Richard Hodes, MD; Lesley Curtis, PhD

Wednesday, May 16, 2018

Welcome and Introduction
David Shurtleff, PhD; Richard Hodes, MD; Catherine Meyers, MD; Wendy Weber, PhD, MPH

Panel Discussions

Panel 1: Partnering With Stakeholders to Conduct Embedded A vs. B Trials: Keys to Success Moderator: Rich Platt, MD, MSc

  • Steve Friedhoff, MD
  • Kenneth Sands, MD, MPH
  • Joseph Chin, MD

Panel 2: Examples in Action: Embedded A vs. B Trials Moderator: Beverly Green, MD, MPH

  • Ryan Ferguson, ScD, MPH
  • Susan Huang, MD, MPH
  • Michael Kappelman, MD, MPH

Panel 3: Maximizing the Pragmatic: Understanding Approaches to Design of Embedded A vs. B Trials Moderator: Greg Simon, MD, MPH

  • Scott Solomon, MD
  • Rachael Fleurence, PhD
  • Kourtney Davis, PhD, MSPH

Panel 4: Regulatory Aspects of Clinical Research and the Regulation of Products for Embedded A vs. B Pragmatic Trials Moderator: Adrian Hernandez 

  • Jacqueline Corrigan-Curay, MD, JD
  • Owen Faris, PhD
  • Julie Kaneshiro, MA

Panel 5: Ethical and IRB Approaches for a Successful Embedded A vs. B Pragmatic Trials Moderator: David Wendler, PhD

  • Barbara Bierer, MD
  • Spencer Hey, PhD
  • Judith Carrithers, JD, MPA

Summary Expert Panel Discussion Moderator: Cathy Meyers, MD

  • Adrian Hernandez, MD
  • Rich Platt, MD, MSc
  • Beverly Green, MD, MPH
  • Greg Simon, MD, MPH
  • Dave Wendler, PhD

Concluding Remarks 
Adrian Hernandez, MD, MHS; Rich Platt, MD, MSc

ePCTs of Therapeutic A vs. B Interventions: NIH-Hosted Workshop (May 2018)

May 16, 2018: This workshop explored challenges and strategies for planning and implementing ePCTs that compare two or more therapeutic medical regimens.

Agenda and Slides

Welcome and Introduction

David Shurtleff, PhD
Richard Hodes, MD
Catherine Meyers, MD
Wendy Weber, PhD, MPH

 

Panel 1: Partnering With Stakeholders to Conduct Embedded A vs. B Trials: Keys to Success

Moderator: Rich Platt, MD, MSc

Panel:

    • Steve Friedhoff, MD
    • Kenneth Sands, MD, MPH
    • Joseph Chin, MD

Panel 2: Examples in Action: Embedded A vs. B Trials

Moderator: Beverly Green, MD, MPH

Panel:

    • Ryan Ferguson, ScD, MPH
    • Susan Huang, MD, MPH
    • Michael Kappelman, MD, MPH

Panel 3: Maximizing the Pragmatic: Understanding Approaches to Design of Embedded A vs. B Trials

Moderator: Greg Simon, MD, MPH

Panel:

    • Scott Solomon, MD
    • Rachael Fleurence, PhD
    • Kourtney Davis, PhD, MSPH

Panel 4: Regulatory Aspects of Clinical Research and the Regulation of Products for Embedded A vs. B Pragmatic Trials

Moderator: Adrian Hernandez, MD

Panel:

    • Jacqueline Corrigan-Curay, MD, JD
    • Owen Faris, PhD
    • Julie Kaneshiro, MA

Panel 5: Ethical and IRB Approaches for a Successful Embedded A vs. B Pragmatic Trials Moderator:

Moderator: David Wendler, PhD

Panel:

    • Barbara Bierer, MD
    • Spencer Hey, PhD
    • Judith Carrithers, JD, MPA

Summary and Concluding Remarks

Moderator: Cathy Meyers, MD

Panel:

    • Adrian Hernandez, MD
    • Rich Platt, MD, MSc
    • Beverly Green, MD, MPH
    • Greg Simon, MD, MPH
    • Dave Wendler, PhD

ePCT Training Workshop Course Materials (February 2018)

February 20-21, 2018: This workshop provided training to mid- to senior-level investigators who are interested in conducting embedded pragmatic clinical trials (ePCTs). During the workshop, the NIH Collaboratory piloted the educational materials for investigators and collected feedback on the quality and appropriateness of the materials.

Agenda and Slides

Day 1: February 20

Welcome and Introduction

Gloria Coronado, PhD
Doug Zatzick, MD

Session 1: What Are Embedded Pragmatic Clinical Trials?

Lesley Curtis, PhD
Gloria Coronado, PhD
Doug Zatzick, MD

Session 2: Engaging All Stakeholders and Aligning With Healthcare System Partners

Leah Tuzzio, MPH

Session 3: Designing With Implementation in Mind

Doug Zatzick, MD

Session 4: Design and Analytic Considerations

Liz Turner, PhD

Session 5: Regulatory and Ethical Challenges of ePCTs

Kevin Weinfurt, PhD

Day 2: February 21

Session 6: Measuring Outcomes

Rachel Richesson, PhD, MPH
Lesley Curtis, PhD

Session 7: Pilot and Feasibility Testing

Wendy Weber, ND, PhD, MPH

Session 8: Dissemination

Doug Zatzick, MD

Session 9: ePCT Team Composition

Lesley Curtis, PhD

Session 10: Developing a Compelling Application

Marcel Salive, MD, MPH